elagolix sodium
Marketedupdated 2mo agoby $ABBV AbbVie Inc.
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval, with an approval for endometriosis.
all catalysts(7)
approval · 7
Jul 23, 2018
approval
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Aug 28, 2019
approval
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Feb 1, 2021
approval
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Feb 1, 2021
approval
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Feb 1, 2021
approval
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Jun 5, 2023
approval
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Dec 17, 2025
approval
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that